000			01933 a2200529 4500
005			20250515125006.0
264		0	_c20080805
008			200808s 0 0 eng d
022			_a1538-7445
024	7		_a10.1158/0008-5472.CAN-07-6484 _2doi
040			_aNLM _beng _cNLM
100	1		_aGough, Michael J
245	0	0	_aOX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor. _h[electronic resource]
260			_bCancer research _cJul 2008
300			_a5206-15 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntibodies _xtherapeutic use
650	0	4	_aAntibodies, Monoclonal _xpharmacology
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aCD8 Antigens _xmetabolism
650	0	4	_aCarcinoma _xdrug therapy
650	0	4	_aChemotaxis, Leukocyte _xdrug effects
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aDrug Evaluation, Preclinical
650	0	4	_aImmune Tolerance _xdrug effects
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMammary Neoplasms, Animal _xdrug therapy
650	0	4	_aMembrane Glycoproteins _xagonists
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, Inbred C57BL
650	0	4	_aMice, Knockout
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aOX40 Ligand
650	0	4	_aT-Lymphocytes, Regulatory _xdrug effects
650	0	4	_aTumor Cells, Cultured
650	0	4	_aTumor Escape _xdrug effects
650	0	4	_aTumor Necrosis Factors _xagonists
700	1		_aRuby, Carl E
700	1		_aRedmond, William L
700	1		_aDhungel, Birat
700	1		_aBrown, Alexis
700	1		_aWeinberg, Andrew D
773	0		_tCancer research _gvol. 68 _gno. 13 _gp. 5206-15
856	4	0	_uhttps://doi.org/10.1158/0008-5472.CAN-07-6484 _zAvailable from publisher's website
999			_c18076794 _d18076794